NOVO NORDISK A/S

NYSE: NVO (Novo Nordisk A/S)

Kemas kini terakhir: 3 jam lalu

43.74

-0.18 (-0.41%)

  • 1H -0.41%
  • 5H 3.67%
  • 1B -1.22%
  • 6B -10.66%
  • Tahun Ke Tarikh -16.51%
  • 1T -43.21%
  • 5T 4.60%
Penutupan Terdahulu 43.92
Buka 44.03
Jumlah Dagangan 4,426,675
Purata Dagangan (3B) 16,127,401
Modal Pasaran 193,726,889,984
Harga / Pendapatan (P/E TTM) 10.32
Harga / Pendapatan (P/E Ke hadapan) 12.35
Harga / Jualan (P/S) 3.69
Harga / Buku (P/B) 5.92
Julat 52 Minggu
35.12 (-19%) — 75.78 (73%)
Tarikh Pendapatan 5 Aug 2026
Hasil Dividen (DY TTM) 3.50%
Margin Keuntungan 34.51%
Margin Operasi (TTM) 49.68%
EPS Cair (TTM) 3.67
Pertumbuhan Hasil Suku Tahunan (YOY) 19.50%
Pertumbuhan Pendapatan Suku Tahunan (YOY) 14.30%
Jumlah Hutang/Ekuiti (D/E MRQ) 85.70%
Nisbah Semasa (MRQ) 0.740
Aliran Tunai Operasi (OCF TTM) 131.24 B
Aliran Tunai Bebas Leveraj (LFCF TTM) 77.73 B
Pulangan Atas Aset (ROA TTM) 23.29%
Pulangan Atas Ekuiti (ROE TTM) 88.12%

Arah Aliran Pasaran

Jangka Pendek Jangka Sederhana
Industri Drug Manufacturers - General (US) Menaik Bercampur
Drug Manufacturers - General (Global) Menaik Bercampur
Stok Novo Nordisk A/S Menaik Menurun

AISkor Stockmoo

0.1
Konsensus Penganalisis 2.0
Aktiviti Orang Dalam NA
Volatiliti Harga 1.0
Purata Bergerak Teknikal 0.0
Osilator Teknikal -2.5
Purata 0.13

Saham Serupa

Stok Modal Pasaran DY P/E (TTM) P/B
NVO 194 B 3.50% 10.32 5.92
NVS 292 B 3.20% 21.93 7.34
LLY 1 T 0.63% 39.97 32.72
JNJ 566 B 2.26% 27.26 7.07
ABBV 391 B 3.18% 108.05 50.46
MRK 294 B 3.86% 33.54 6.50

With roughly one-third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (contributing less than 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Sektor Healthcare
Industri Drug Manufacturers - General
Gaya Pelaburan Large Core
% Dimiliki oleh Orang Dalam 0.01%
% Dimiliki oleh Institusi 9.85%

Pemilikan

Nama Tarikh Syer Dipegang
Everett Harris & Co /Ca/ 31 Mar 2026 6,424,661

Tiada data dalam julat masa ini.

Tiada data dalam julat masa ini.

  • 3M
Tarikh Jenis Butiran
13 Jun 2026 CNBC Drugmakers race to find a place in the next wave of obesity drugs
09 Jun 2026 CNBC Novo and Lilly are competing to win the GLP-1 pill market as they prepare for Medicare coverage
28 May 2026 CNBC CVS to restore coverage of Zepbound, add Eli Lilly's obesity pill to drug plans
06 May 2026 CNBC Novo Nordisk CEO says the drugmaker is more active than ever in seeking out deals
04 May 2026 CNBC Novo Nordisk’s head start on GLP-1 pills forces investors to rethink Eli Lilly's dominance
02 May 2026 CNBC Weight loss and hair loss: The growing hair treatment market from GLP-1s
30 Apr 2026 CNBC Eli Lilly blows past quarterly estimates, hikes outlook as Zepbound and Mounjaro sales skyrocket
30 Apr 2026 CNBC FDA proposes excluding Novo, Lilly weight loss drugs from bulk compounding list in win for the companies
21 Apr 2026 CNBC Amazon launches GLP-1 weight loss program, promising 'fast, convenient' access
09 Apr 2026 CNBC As millions lose weight on GLP-1s, they're starting to turn to retailers to refresh their wardrobes
08 Apr 2026 CNBC Trump administration sets up to 100% tariffs on some imported drugs, with many companies exempt
07 Apr 2026 CNBC Novo Nordisk's explosive Wegovy pill launch draws a new wave of patients into GLP-1 weight loss treatment
03 Apr 2026 CNBC Trump tariff fallout: Some industries grapple with lingering effects one year later
31 Mar 2026 CNBC Novo Nordisk launches multi-month subscriptions for Wegovy obesity drugs as it tries to catch up with Eli Lilly
23 Mar 2026 CNBC GLP-1 drugs are changing how Americans eat. Food companies are racing to catch up
19 Mar 2026 CNBC FDA approves higher dose version of weight loss drug Wegovy as Novo Nordisk tries to win back market share
Papar semua
Hasil Dividen (DY TTM) 3.50%
Purata Hasil Dividen 5T 2.17%
Nisbah Pembayaran 47.09%
Tarikh EX Tarikh Pengumuman Tarikh Pembayaran Perincian
31 Mar 2025 05 Feb 2025 08 Apr 2025 1.099206 Tunai
16 Aug 2024 06 Aug 2024 26 Aug 2024 0.5126402 Tunai
22 Mar 2024 31 Jan 2024 02 Apr 2024 0.92985 Tunai
18 Aug 2023 10 Aug 2023 29 Aug 2023 0.8835613 Tunai
24 Mar 2023 02 Feb 2023 04 Apr 2023 1.1887415 Tunai
12 Aug 2022 04 Aug 2022 23 Aug 2022 0.5835507 Tunai
25 Mar 2022 02 Mar 2022 05 Apr 2022 1.022423 Tunai
16 Aug 2021 - 25 Aug 2021 0.5502889 Tunai
26 Mar 2021 - 07 Apr 2021 0.922122 Tunai
14 Aug 2020 06 Aug 2020 25 Aug 2020 0.5177774 Tunai
27 Mar 2020 06 Feb 2020 07 Apr 2020 0.7826048 Tunai
16 Aug 2019 10 Aug 2019 27 Aug 2019 0.449438 Tunai
22 Mar 2019 05 Feb 2019 02 Apr 2019 0.777006 Tunai
17 Aug 2018 09 Aug 2018 28 Aug 2018 0.462327 Tunai
23 Mar 2018 24 Mar 2018 03 Apr 2018 0.805982 Tunai
17 Aug 2017 - 29 Aug 2017 0.33589 Tunai
23 Mar 2017 - 04 Apr 2017 0.479369 Tunai
11 Aug 2016 - 23 Aug 2016 0.331026 Tunai
18 Mar 2016 - 30 Mar 2016 0.69943 Tunai
19 Mar 2015 - 31 Mar 2015 0.532885 Tunai
21 Mar 2014 - 02 Apr 2014 0.606122 Tunai
21 Mar 2013 - 02 Apr 2013 2.264307 Tunai
22 Mar 2012 - 03 Apr 2012 1.831902 Tunai
24 Mar 2011 - 05 Apr 2011 1.357901 Tunai
25 Mar 2010 - 07 Apr 2010 0.978615 Tunai
19 Mar 2009 - 31 Mar 2009 0.781532 Tunai
13 Mar 2008 - 25 Mar 2008 0.678462 Tunai
08 Mar 2007 - 20 Mar 2007 0.891779 Tunai
09 Mar 2006 - 21 Mar 2006 0.691753 Tunai
10 Mar 2005 - 22 Mar 2005 0.61725 Tunai
17 Mar 2004 - 29 Mar 2004 0.52096 Tunai
26 Mar 2003 - 07 Apr 2003 0.37647 Tunai
13 Mar 2002 - 25 Mar 2002 0.2848 Tunai
21 Mar 2001 - 02 Apr 2001 0.5681 Tunai
24 Mar 2000 - 06 Apr 2000 0.4672 Tunai
25 Mar 1999 - 06 Apr 1999 0.4182 Tunai
27 Mar 1998 - 08 Apr 1998 0.3051 Tunai
25 Apr 1997 - 07 May 1997 0.239 Tunai
01 May 1996 - 14 May 1996 0.1806 Tunai
Papar semua

Hasil Dividen Tahunan

Tahun Dividen Tahunan ($) Kekerapan/Tahun Hasil %
2025 1.10 1 2.16
2024 1.44 2 1.68
2023 2.07 2 2.00
2022 1.61 2 2.37
2021 1.47 2 2.63
2020 1.30 2 3.72
2019 1.23 2 4.24
2018 1.27 2 5.51
2017 0.815 2 3.04
2016 1.03 2 5.75
2015 0.533 1 1.84
2014 0.606 1 2.86
2013 2.26 1 12.26
2012 1.83 1 11.22
2011 1.36 1 11.78
2010 0.979 1 8.69
2009 0.782 1 12.24
2008 0.678 1 13.20
2007 0.892 1 13.75
2006 0.692 1 16.54
2005 0.617 1 21.94
2004 0.521 1 19.20
2003 0.376 1 18.38
2002 0.285 1 19.71
2001 0.568 1 28.33
2000 0.467 1 26.40
1999 0.418 1 32.36
1998 0.305 1 22.94
1997 0.239 1 16.57
1996 0.181 1 19.32
Papar semua

Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.

Portfolio

AI Templat

Peringatan harga anda

Profil Risiko

| | | | |
Konservatif
Sederhana Konservatif
Sederhana
Sederhana Agresif
Agresif
Margin Keselamatan (EP)
Keuntungan Separa (TP1)
Keuntungan Sasaran (TP2)
Kerugian Maksimum (SL)

Penafian: Perkara di atas adalah untuk tujuan ilustrasi sahaja dan BUKAN nasihat pelaburan. Dapatkan nasihat daripada penasihat kewangan yang berkelayakan.

Harga Masuk (EP)

Ambil Untung 1 (TP1)

Ambil Untung 2 (TP2)

Henti Rugi (SL)

Julat 52 Minggu
 
52WL
 
52WH
SL
EP
TP1
TP2

Semua harga peringatan berada dalam julat harga 52 minggu

Keuntungan Nyata -
Keuntungan Tidak Nyata -
Dividen Diterima 2026 -
Jumlah Untung -
Pulangan Purata -
Kuantiti (Beli) -
Purata Harga (Beli) -
Kuantiti (Jual) -
Purata Harga (Jual) -
Tiada saham yang memenuhi kriteria anda